Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Disclosures


Our current, in-kind benefits and value received from organisations we work with.

While our overarching funding comes from NHS England and the Government’s Office for Life Sciences, for some programmes of work, where appropriate, we develop joint working agreements with commercial organisations.

In some instances this includes additional funding which enables the health innovation networks and NHS to reach more patients, while ensuring the health and care system benefit from the very best innovations in health and care.

Known as a ‘transfer of value’ this could be a direct payment from industry to a regional health innovation network towards an Health Innovation Network project or programme, or a secondment of staff from industry to support Health Innovation Network projects.

Below is our register of current, in-kind benefits and value received from organisations we work with.

Organisations involved KSS AHSN

Amgen UK Limited

In-kind benefit or value received £4.6k
Dates covered December 2023 – June 2024
Summary of in-kind benefit or value received Donation of in kind support – for process mapping
AHSN owner enquiries@healthinnovation-kss.com

 

Organisations involved KSS AHSN

Novartis Pharmaceuticals UK Limited

In-kind benefit or value received £4k (in-kind benefit received)
Dates covered May 2022 – September 2022
Summary of in-kind benefit or value received Collaborative Working Agreement (in kind support only) to map service pathways (through workshops and interviews) to improve efficiency and service effectiveness to benefit of patient care.
AHSN owner enquiries@healthinnovation-kss.com

 

Organisations involved KSS AHSN

Novartis Pharmaceuticals UK Limited

In-kind benefit or value received £8.6k (of which £8k is payment)
Dates covered November 2022 – April 2024
Summary of in-kind benefit or value received Collaborative Working Agreement (in kind support only) to deliver the benefits to patients of supporting deployment of a mental health app to help improve the well-being of NHS staff, reducing absenteeism and staff turnover, resulting in a better service or patients.
AHSN owner enquiries@healthinnovation-kss.com